The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
The company showcased three core programs developed through this platform
These medicines are essential in preventing RhD immunisation during pregnancy
Commercial production is expected to begin soon
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Subscribe To Our Newsletter & Stay Updated
